|
|
|
Volumn 51, Issue RR-18, 2002, Pages
|
|
U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
MITOCHONDRIAL DNA;
PROTEINASE INHIBITOR;
ANTIBIOTIC RESISTANCE;
ARTICLE;
CLINICAL TRIAL;
DELIVERY;
DISEASE TRANSMISSION;
DRUG EFFECT;
FEMALE;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERGLYCEMIA;
LABOR;
MATERNAL CARE;
NEWBORN;
PRACTICE GUIDELINE;
PREGNANCY;
PREGNANCY COMPLICATION;
PREGNANCY OUTCOME;
REGISTER;
STANDARD;
UNITED STATES;
VIRUS LOAD;
ANTI-HIV AGENTS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CLINICAL TRIALS;
DELIVERY, OBSTETRIC;
DISEASE TRANSMISSION, VERTICAL;
DNA, MITOCHONDRIAL;
DRUG RESISTANCE, VIRAL;
FEMALE;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HIV-1;
HUMANS;
HYPERGLYCEMIA;
INFANT, NEWBORN;
LABOR, OBSTETRIC;
PRECONCEPTION CARE;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
PREGNANCY OUTCOME;
REGISTRIES;
UNITED STATES;
VIRAL LOAD;
|
|
EID: 0037159519
PISSN: 10575987
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (123)
|
|
References (0)
|
